lansoprazole has been researched along with mocetinostat in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hibi, T; Ishii, H; Iwai, N; Miyayama, A; Mori, M; Oonuki, M; Suzuki, H; Suzuki, M; Tsunematsu, N | 1 |
| Ishii, H; Kitahora, T; Miyazawa, M; Nagahashi, S; Suzuki, H; Suzuki, K; Suzuki, M | 1 |
| Ichikawa, H; Kuroda, M; Naito, Y; Okanoue, T; Okuda, T; Takagi, T; Yoshida, N; Yoshikawa, T | 1 |
| Bertini, S; Cavestro, GM; Coruzzi, G; Grandi, D; Menozzi, A; Ossiprandi, MC; Pozzoli, C; Solenghi, E; Zullian, C | 1 |
| Cadirci, E; Dengiz, GO; Halici, Z; Odabasoglu, F; Suleyman, H | 1 |
| Kaur, S; Kochhar, R; Prasad, KK; Ray, P; Vaishnavi, C | 2 |
| Amagase, K; Higuchi, K; Kakimoto, K; Kato, S; Murano, M; Nishio, H; Takeuchi, K; Tokioka, S; Umegaki, E; Yoda, Y | 1 |
| Singh, N; Sodhi, RK | 1 |
| Gandhi, T; Gupta, P; Parikh, M; Shah, H; Sharma, A; Vyas, N | 1 |
1 trial(s) available for lansoprazole and mocetinostat
| Article | Year |
|---|---|
Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Biopsy; Duodenal Ulcer; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Neutrophils; Omeprazole; Peroxidase; Proton Pump Inhibitors; Pyloric Antrum; Rabeprazole; Stomach Ulcer | 2002 |
9 other study(ies) available for lansoprazole and mocetinostat
| Article | Year |
|---|---|
Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lansoprazole; Male; Middle Aged; Neutrophils; Omeprazole; Peroxidase; Proton Pump Inhibitors; Stomach Ulcer | 1997 |
Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CXCL1; Chemokines, CXC; Enteritis; Indomethacin; Intercellular Signaling Peptides and Proteins; Intestinal Mucosa; Intestine, Small; Lansoprazole; Male; Omeprazole; Peroxidase; Proton Pump Inhibitors; Proton Pumps; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2006 |
Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Translocation; Dose-Response Relationship, Drug; Humans; Indomethacin; Intestinal Mucosa; Intestine, Small; Intubation, Gastrointestinal; Jejunum; Lansoprazole; Male; Malondialdehyde; Neutrophil Infiltration; Omeprazole; Oxidative Stress; Peroxidase; Proton Pump Inhibitors; Rats; Rats, Wistar; Severity of Illness Index | 2007 |
Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetates; Animals; Anti-Ulcer Agents; Antioxidants; Catalase; Cyclopropanes; Dose-Response Relationship, Drug; Famotidine; Gastrointestinal Agents; Glutathione Reductase; Glutathione Transferase; Histamine H2 Antagonists; Indomethacin; Intubation, Gastrointestinal; Lansoprazole; Male; Molecular Structure; Peroxidase; Quinolines; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach; Stomach Ulcer; Sulfides; Superoxide Dismutase | 2007 |
Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colony Count, Microbial; Enterocolitis, Pseudomembranous; Enterotoxins; Intestines; Lansoprazole; Mice; Mice, Inbred BALB C; Peroxidase; Proton Pump Inhibitors | 2007 |
Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colony Count, Microbial; Enterobacteriaceae; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Lansoprazole; Male; Nitric Oxide Synthase Type II; Organometallic Compounds; Peroxidase; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Ulcer | 2010 |
Effect of Lactobacillus acidophilus & epidermal growth factor on experimentally induced Clostridium difficile infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ampicillin; Animals; Cecum; Clostridioides difficile; Colon; Disease Models, Animal; Enterocolitis, Pseudomembranous; Epidermal Growth Factor; Ileum; Lactobacillus acidophilus; Lansoprazole; Mice; Mice, Inbred BALB C; Peroxidase; Probiotics | 2011 |
Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet.
Topics: Acetylcholinesterase; Alzheimer Disease; Analysis of Variance; Animals; Body Weight; Brain; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; Female; Glutathione; Injections, Intraventricular; Lansoprazole; Male; Maze Learning; Memory; Mice; Peroxidase; Proton Pump Inhibitors; Streptozocin; Thiobarbituric Acid Reactive Substances | 2013 |
Lansoprazole a Proton Pump Inhibitor Prevents IBD by Reduction of Oxidative Stress and NO Levels in the Rat.
Topics: Animals; Colitis; Colon; Female; Inflammatory Bowel Diseases; Lansoprazole; Nitric Oxide; Oxidative Stress; Peroxidase; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley | 2021 |